Komo Plant-Based Foods Announces Record Revenues in December - with 35% Profit Margin Reported Last Quarter Company News
AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation to Telisotuzumab Vedotin for Previously Treated Non-Small Cell Lung Cancer Pharmaceutical Investing
Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference Pharmaceutical Investing
